Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

Chemical Reviews
Craig W LindsleyP Jeffrey Conn

Abstract

Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats. Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacology, unprecedented subtype selectivity, and unique signal bias. This review provides a comprehensive overview of the basics of GPCR allosteric pharmacology, medicinal chemistry, drug metabolism, and validated approaches to address each of the major challenges and caveats. Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("molecular switches", signal bias, heterodimers) and practical solutions to enable the development of tool compounds and clinical candidates. The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.

References

Aug 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·C B Pert, S H Snyder
Dec 22, 1983·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J W Black, P Leff
Nov 8, 1996·The Journal of Biological Chemistry·C RomanoK L O'Malley
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·P J Conn, J P Pin
Oct 26, 1999·Neuropharmacology·D D SchoeppJ A Monn
Jun 8, 2000·The Journal of Biological Chemistry·S R GeorgeB F O'Dowd
Aug 17, 2001·The Journal of Biological Chemistry·S AbdAllaU Quitterer
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·F KnoflachJ A Kemp
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·H MöhlerU Rudolph
Jan 30, 2002·Bioorganic & Medicinal Chemistry Letters·Fabrizio GaspariniRainer Kuhn
May 31, 2002·Pharmacological Reviews·Arthur Christopoulos, Terry Kenakin
Jul 16, 2002·Pharmacology, Biochemistry, and Behavior·Tracey K MurrayMichael J O'Neill
Jul 18, 2002·Nature Reviews. Drug Discovery·Arthur Christopoulos
Apr 1, 2003·Nature Neuroscience·Barbara PicconiPaolo Calabresi
Apr 10, 2003·British Journal of Pharmacology·Jesper Mosolff MathiesenM Teresa Ramirez
Aug 16, 2003·Molecular Pharmacology·Julie A O'BrienDavid L Williams
Sep 18, 2003·Stress : the International Journal on the Biology of Stress·Darryle D SchoeppWilliam Z Potter
May 1, 1965·Journal of Molecular Biology·J MONODJ P CHANGEUX
Nov 1, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michael J MarinoP Jeffrey Conn
Nov 26, 2003·Cell·Grace Q ZhaoCharles S Zuker
Jan 30, 2004·The Journal of Pharmacology and Experimental Therapeutics·Julie A O'BrienDavid L Williams

❮ Previous
Next ❯

Citations

Dec 15, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Katie Leach, Karen J Gregory
Dec 15, 2016·The Journal of Organic Chemistry·Abhijit R KulkarniGanesh A Thakur
Jan 20, 2017·ACS Chemical Neuroscience·Robert B LaprairieGanesh A Thakur
Jan 10, 2017·Expert Opinion on Therapeutic Patents·Kyle A Emmitte
Aug 10, 2016·Bioorganic & Medicinal Chemistry Letters·Alexander R GeanesCraig W Lindsley
Jul 2, 2019·Journal of Biomolecular Structure & Dynamics·Balázs JójártGyörgy M Keserű
Sep 6, 2019·Physiological Reviews·Ikuo KimuraMiki Igarashi
Aug 9, 2019·Current Topics in Medicinal Chemistry·Zoltán OrgovánGyörgy M Keserű
Feb 13, 2020·Natural Product Reports·Marjorie BruderDaniela B B Trivella
Jan 25, 2020·British Journal of Pharmacology·David B FinlayMichelle Glass
Apr 2, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Víctor Fernández-DueñasFrancisco Ciruela
Oct 5, 2019·Bioscience, Biotechnology, and Biochemistry·Zengliang ZhangShuxun Hou
Jul 21, 2020·ChemMedChem·Zoltán OrgovánGyörgy M Keserű
Mar 24, 2020·Letters in Drug Design & Discovery·Mark Gallant FultonCraig William Lindsley
Apr 30, 2017·Molecular Neurobiology·Grzegorz SatałaAndrzej J Bojarski
Mar 23, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Claudia Llinas Del TorrentGary Tresadern
Jan 22, 2019·Frontiers in Molecular Neuroscience·Vanessa Pereira, Cyril Goudet
Jun 27, 2019·Expert Opinion on Therapeutic Patents·Andrés A TrabancoJosé María Cid
May 19, 2020·Depression and Anxiety·A Irem SonmezPaul E Croarkin
Apr 10, 2020·Frontiers in Pharmacology·David B FinlayMichelle Glass
Nov 6, 2020·Nature·Joshua C Snyder, Sudarshan Rajagopal
Jan 9, 2021·Signal Transduction and Targeted Therapy·Dehua YangMing-Wei Wang
Aug 26, 2018·Bioorganic & Medicinal Chemistry·Christina GatesN R Natale
Mar 3, 2020·Biochemical Pharmacology·O KeiferD Bertrand
Mar 16, 2021·Expert Opinion on Therapeutic Patents·Alshaima'a M Qunies, Kyle A Emmitte
Aug 18, 2020·Neurobiology of Disease·Julia ForstenpointnerDavid Borsook

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.